The Use of Peptides in the Treatment of Fragile X Syndrome: Challenges and Opportunities
Fragile X Syndrome (FXS) is the most frequent cause of inherited intellectual disabilities and autism spectrum disorders, characterized by cognitive deficits and autistic behaviors. The silencing of the Fmr1 gene and consequent lack of FMRP protein, is the major contribution to FXS pathophysiology....
Guardado en:
Autores principales: | Alice Romagnoli, Daniele Di Marino |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/0c86197a80b2456d8ce7f450ab063d4f |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Fragile X Syndrome and Targeted Treatments
por: Nattaporn Tassanakijpanich, et al.
Publicado: (2020) -
Maternal Mental Health and Parenting Stress and Their Relationships to Characteristics of the Child With Fragile X Syndrome
por: Lauren Bullard, et al.
Publicado: (2021) -
Neural Correlates of Infant Face Processing and Later Emerging Autism Symptoms in Fragile X Syndrome
por: Maggie W. Guy, et al.
Publicado: (2021) -
EEG Signal Complexity Is Reduced During Resting-State in Fragile X Syndrome
por: Mélodie Proteau-Lemieux, et al.
Publicado: (2021) -
Síndrome del X-Frágil: Discusión del Primer Caso confirmado citogenéticamente en Chile
por: Lacassle S,Yves, et al.
Publicado: (1983)